Cancer vaccines: progress reveals new complexities.
Yu
Zhiya
Z
National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1502, USA.
Restifo
Nicholas P
NP
D000951:Antigens, Neoplasm / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology*; D002986:Clinical Trials as Topic; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation; D009369:Neoplasms / Q000276:immunology / Q000517:prevention & control*
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D018984:Epitopes, T-Lymphocyte